REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 47 filers reported holding REGULUS THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $56,000 | – | 78,587 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 327,350 | $2,943,000 | 1.62% |
| HealthCor Management, L.P. | 1,575,000 | $14,207,000 | 0.86% |
| Cormorant Asset Management, LP | 200,000 | $1,804,000 | 0.42% |
| BVF INC/IL | 184,999 | $1,669,000 | 0.26% |
| Verity Asset Management, Inc. | 28,410 | $244,000 | 0.25% |
| Callan Capital, LLC | 80,478 | $726,000 | 0.24% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 225,000 | $2,029,000 | 0.22% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 61,846 | $558,000 | 0.05% |
| LMR Partners LLP | 11,815 | $106,000 | 0.02% |
| Weiss Multi-Strategy Advisers LLC | 70,000 | $631,000 | 0.01% |